|
1
|
Frank RN: Diabetic retinopathy. N Engl J
Med. 350:48–58. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roglic G: WHO Global report on diabetes: A
summary. Int J Noncommun Dis. 1:3–8. 2016. View Article : Google Scholar
|
|
3
|
Zheng Y, He M and Congdon N: The worldwide
epidemic of diabetic retinopathy. Indian J Ophthalmol. 60:428–431.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Simó R, Villarroel M, Corraliza L,
Hernández C and Garcia-Ramírez M: The retinal pigment epithelium:
Something more than a constituent of the blood-retinal
barrier-implications for the pathogenesis of diabetic retinopathy.
J Biomed Biotechnol. 2010:1907242010. View Article : Google Scholar
|
|
5
|
Chiba C: The retinal pigment epithelium:
An important player of retinal disorders and regeneration. Exp Eye
Res. 123:107–114. 2014. View Article : Google Scholar
|
|
6
|
Spekker-Bosker K, Ufermann CM, Oldenburg
M, Däubener W and Eller SK: Interplay between IDO1 and iNOS in
human retinal pigment epithelial cells. Med Microbiol Immunol.
208:811–824. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tsao YP, Ho TC, Chen SL and Cheng HC:
Pigment epithelium-derived factor inhibits oxidative stress-induced
cell death by activation of extracellular signal-regulated kinases
in cultured retinal pigment epithelial cells. Life Sci. 79:545–550.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Seagle BL, Gasyna EM, Mieler WF and Norris
JR Jr: Photoprotection of human retinal pigment epithelium cells
against blue light-induced apoptosis by melanin free radicals from
Sepia officinalis. Proc Natl Acad Sci USA. 103:16644–16648. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Steindl K and Binder S: Retinal
degeneration processes and transplantation of retinal pigment
epithelial cells: Past, present and future trends. Spektrum der
Augenheilkunde. 22:357–361. 2008. View Article : Google Scholar
|
|
10
|
Ren S, Zhang H, Mu Y, Sun M and Liu P:
Pharmacological effects of Astragaloside IV: A literature review. J
Tradit Chin Med. 33:413–416. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lia L, Houb X, Xub R, Liua C and Tub M:
Research review on the pharmacological effects of astragaloside IV.
Fundam Clin Pharmacol. 31:17–36. 2017. View Article : Google Scholar
|
|
12
|
Zhang Z, Sun J, Hu Y, Song C and Wu X:
miR-128 protects retinal pigment epithelium in high glucose through
HOXB3/PI3K/ERK-mTOR pathway. Int J Clin Exp Med. 9:1684–1691.
2016.
|
|
13
|
Chakraborty C, George Priya Doss C and
Bandyopadhyay S: miRNAs in insulin resistance and
diabetes-associated pancreatic cancer: The 'minute and miracle'
molecule moving as a monitor in the 'genomic galaxy'. Curr Drug
Targets. 14:1110–1117. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chakraborty C, Doss CG, Bandyopadhyay S
and Agoramoorthy G: Influence of miRNA in insulin signaling pathway
and insulin resistance: Micro-molecules with a major role in type-2
diabetes. Wiley Interdiscip Rev RNA. 5:697–712. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ciccacci C, Morganti R, Di Fusco D,
D'Amato C, Cacciotti L, Greco C, Rufini S, Novelli G, Sangiuolo F,
Marfia GA, et al: Common polymorphisms in MIR146a, MIR128a and
MIR27a genes contribute to neuropathy susceptibility in type 2
diabetes. Acta Diabetol. 51:663–671. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ding Y, Yuan S, Liu X, Mao P, Zhao C,
Huang Q, Zhang R, Fang Y, Song Q, Yuan D, et al: Protective effects
of astragalo-side IV on db/db mice with diabetic retinopathy. PLoS
One. 9:e1122072014. View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
18
|
Gui D, Huang J, Guo Y, Chen J, Chen Y,
Xiao W, Liu X and Wang N: Astragaloside IV ameliorates renal injury
in streptozotocin-induced diabetic rats through inhibiting
NF-κB-mediated inflammatory genes expression. Cytokine. 61:970–977.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen M, Wang W, Ma J, Ye P and Wang K:
High glucose induces mitochondrial dysfunction and apoptosis in
human retinal pigment epithelium cells via promoting SOCS1 and
Fas/FasL signaling. Cytokine. 78:94–102. 2016. View Article : Google Scholar
|
|
20
|
Crider JY, Yorio T, Sharif NA and Griffin
BW: The effects of elevated glucose on Na+/K(+)-ATPase of cultured
bovine retinal pigment epithelial cells measured by a new
nonradioactive rubidium uptake assay. J Ocul Pharmacol Ther.
13:337–352. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yin B, Hou XW and Lu ML: Astragaloside IV
attenuates myocardial ischemia/reperfusion injury in rats via
inhibition of calcium-sensing receptor-mediated apoptotic signaling
pathways. Acta Pharmacol Sin. 40:599–607. 2019. View Article : Google Scholar :
|
|
22
|
Xiong M, He Q, Lai H and Wang J:
Astragaloside IV inhibits apoptotic cell death in the guinea pig
cochlea exposed to impulse noise. Acta Otolaryngol. 132:467–474.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hengartner MO: The biochemistry of
apoptosis. Nature. 407:770–776. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ugarte-Uribe B and García-Sáez AJ:
Apoptotic foci at mitochondria: In and around Bax pores. Philos
Trans R Soc Lond B Biol Sci. 372:pii: 20160217. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Olson M and Kornbluth S: Mitochondria in
apoptosis and human disease. Curr Mol Med. 1:91–122. 2001.
View Article : Google Scholar
|
|
26
|
Stel AJ, Ten Cate B, Jacobs S, Kok JW,
Spierings DC, Dondorff M, Helfrich W, Kluin-Nelemans HC, de Leij
LF, Withoff S and Kroesen BJ: Fas receptor clustering and
involvement of the death receptor pathway in rituximab-mediated
apoptosis with concomitant sensitization of lymphoma B cells to
fas-induced apoptosis. J Immunol. 178:2287–2295. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nagata S and Golstein P: The Fas death
factor. Science. 267:1449–1456. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Franke TF, Hornik CP, Segev L, Shostak GA
and Sugimoto C: PI3K/Akt and apoptosis: Size matters. Oncogene.
22:8983–8998. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tsuruta F, Masuyama N and Gotoh Y: The
phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax
translocation to mitochondria. J Biol Chem. 277:14040–14047. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao P, Meng Q, Liu LZ, You YP, Liu N and
Jiang BH: Regulation of survivin by PI3K/Akt/p70S6K1 pathway.
Biochem Biophys Res Commun. 395:219–224. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chai X, Sun D, Han Q, Yi L, Wu Y and Liu
X: Hypoxia induces pulmonary arterial fibroblast proliferation,
migration, differentiation and vascular remodeling via the
PI3K/Akt/p70S6K signaling pathway. Int J Mol Med. 41:2461–2472.
2018.PubMed/NCBI
|
